(Q43174148)

15 November 2017

Response to zolendronic acid in children with type III osteogenesis imperfecta (English)

1 reference

15 November 2017

osteogenesis imperfecta

0 references

author

Inusha Panigrahi

1

1 reference

15 November 2017

Rashmi Ranjan Das

2

1 reference

15 November 2017

Sheetal Sharda

3

1 reference

15 November 2017

Ram Kumar Marwaha

4

1 reference

15 November 2017

Niranjan Khandelwal

5

1 reference

15 November 2017

4 February 2010

1 reference

Journal of Bone and Mineral Metabolism

15 November 2017

1 reference

15 November 2017

28

1 reference

15 November 2017

4

1 reference

15 November 2017

451-455

1 reference

https://scigraph.springernature.com/pub.10.1007/s00774-009-0149-4

15 November 2017

0 references

cites work

Safety and efficacy of intravenous zoledronic acid in paediatric osteoporosis.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00774-009-0149-4

Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid

21 January 2018

1 reference

12 December 2020

Bisphosphonate treatment in osteogenesis imperfecta: which drug, for whom, for how long?

1 reference

12 December 2020

Zoledronic acid: a new parenteral bisphosphonate

1 reference

12 December 2020

Bone mineral content and density in healthy subjects and in osteogenesis imperfecta

1 reference

12 December 2020

Osteogenesis imperfecta: A clinical study of the first ten years of life

1 reference

12 December 2020

Osteogenesis imperfecta

1 reference

12 December 2020

Consistent linkage of dominantly inherited osteogenesis imperfecta to the type I collagen loci: COL1A1 and COL1A2.

1 reference

12 December 2020

Intravenous zoledronic acid in postmenopausal women with low bone mineral density

1 reference

12 December 2020

Lumbar spine bone density in Argentine children

1 reference

12 December 2020

Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease.

1 reference

12 December 2020

Differing lumbar vertebral mineralization rates in ambulatory pediatric patients with osteogenesis imperfecta

1 reference

12 December 2020

Two-year clinical trial of oral alendronate versus intravenous pamidronate in children with osteogenesis imperfecta

1 reference

12 December 2020

Cyclic administration of pamidronate in children with severe osteogenesis imperfecta

1 reference

12 December 2020

10.1007/S00774-009-0149-4

Identifiers

DOI

1 reference

Dimensions Publication ID

15 November 2017

0 references

1 reference